CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and ...

Nvelop Therapeutics, a biotechnology company engineering programmable, non-viral vehicles for the in vivo delivery of therapeutic cargo, today announc ...

Voyager Therapeutics, Inc. ( NASDAQ: VYGR) Citi's Biopharma Back to School Conference September 2, 2025 4:00 PM EDT ...

Filed in support of the Company’s CYB004 pre-clinical development program, the PCT filing serves to increase the Company’s library of drug delivery modalities directed to optimal delivery of ...

A subcommittee will assess the program's offerings as a portfolio and explore delivery modalities to ensure alignment with industry. Potential changes to assessment methods ...

Other telehealth modalities, such as remote patient monitoring, virtual check-ins, and e-consultation, stand to more fundamentally disrupt care by liberating the delivery of personalized, timely ...